BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27581359)

  • 1. Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation.
    Druhan LJ; McMahon DP; Steuerwald N; Price AE; Lance A; Gerber JM; Avalos BR
    Blood; 2016 Oct; 128(16):2097-2099. PubMed ID: 27581359
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation.
    Kawashima I; Kumagai T; Suzuki M; Suzuki J; Koshiishi M; Nakajima K; Kirito K
    Ann Hematol; 2019 Sep; 98(9):2249-2250. PubMed ID: 31240470
    [No Abstract]   [Full Text] [Related]  

  • 3. Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia.
    Duployez N; Willekens C; Plo I; Marceau-Renaut A; de Botton S; Fenwarth L; Boyer T; Huet G; Nibourel O; Rose C; Nelken B; Quesnel B; Preudhomme C
    Blood; 2019 Dec; 134(26):2414-2416. PubMed ID: 31697825
    [No Abstract]   [Full Text] [Related]  

  • 4. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.
    Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR
    Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
    Maxson JE; Luty SB; MacManiman JD; Abel ML; Druker BJ; Tyner JW
    J Biol Chem; 2014 Feb; 289(9):5820-7. PubMed ID: 24403076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for
    Ye P; Lin Q; Jin M; Gu X; Lu Y
    Turk J Haematol; 2023 Feb; 40(1):73-74. PubMed ID: 36510384
    [No Abstract]   [Full Text] [Related]  

  • 8. CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation.
    Sun H; Zhu Y; Li J; Zhao L; Yan Z; Zhang S
    Br J Haematol; 2024 Mar; 204(3):e31-e33. PubMed ID: 38262633
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of ruxolitinib on secondary myelofibrosis following chronic neutrophilic leukemia with the CSF3R T618I mutation.
    Ikeda Y; Yamanouchi J; Takenaka K
    Ann Hematol; 2021 Oct; 100(10):2639-2641. PubMed ID: 32676732
    [No Abstract]   [Full Text] [Related]  

  • 10. CALR mutation studies in chronic neutrophilic leukemia.
    Lasho TL; Elliott MA; Pardanani A; Tefferi A
    Am J Hematol; 2014 Apr; 89(4):450. PubMed ID: 24421250
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
    Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
    Mitsumori T; Komatsu N; Kirito K
    Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity.
    Hollander MJ; Malaker SA; Riley NM; Perez I; Abney NM; Gray MA; Maxson JE; Cochran JR; Bertozzi CR
    J Biol Chem; 2023 Jun; 299(6):104755. PubMed ID: 37116708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
    Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
    Yin B; Chen X; Gao F; Li J; Wang HW
    Hematology; 2019 Dec; 24(1):538-543. PubMed ID: 31315541
    [No Abstract]   [Full Text] [Related]  

  • 17. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
    Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW
    Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Tyner JW; Gotlib J
    Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.
    Stahl M; Xu ML; Steensma DP; Rampal R; Much M; Zeidan AM
    Ann Hematol; 2016 Jun; 95(7):1197-200. PubMed ID: 27068405
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic neutrophilic leukemia with CSF3R mutation and concurrent multiple myeloma: one case report].
    He M; Zhao XC; Bai H
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1052. PubMed ID: 32023742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.